Ohio State University Assigned Patent

ALEXANDRIA, Va., Nov. 24 -- Ohio State University, Columbus, Ohio, has been assigned a patent (8,313,950) developed by Brad H. Rovin, Columbus, Ohio, and Xiaolan Zhang, Columbus, Ohio, for "hepcidins as biomarkers for impending lupus nephritis flare." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Biomarkers for determining a kidney flare episode in systemic lupus erythematosus are described." The patent application was filed on May 19, 2008 (12/600,890)...